Ember Therapeutics Valuation
| EMBT Stock | USD 0.0001 0.00 0.00% |
Ember Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Ember Therapeutics from reviewing the firm fundamentals such as Shares Owned By Insiders of 65.00 %, price to earning of 26.61 X, and EBITDA of 9.4 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ember Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Ember Therapeutics is based on 3 months time horizon. Increasing Ember Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Ember Therapeutics' intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of Ember Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ember Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ember Therapeutics helps investors to forecast how Ember pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ember Therapeutics more accurately as focusing exclusively on Ember Therapeutics' fundamentals will not take into account other important factors: About Ember Therapeutics Valuation
The pink sheet valuation mechanism determines Ember Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Ember Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ember Therapeutics. We calculate exposure to Ember Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ember Therapeutics's related companies.Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. Ember Therapeutics, Inc. was founded in 2010 and is headquartered in New York, New York. Ember Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Ember Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ember Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ember Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ember Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ember Therapeutics' revenue streams: Identify Ember Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ember Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ember Therapeutics' growth potential: Evaluate Ember Therapeutics' management, business model, and growth potential.
- Determine Ember Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ember Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Ember Pink Sheet Analysis
When running Ember Therapeutics' price analysis, check to measure Ember Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ember Therapeutics is operating at the current time. Most of Ember Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ember Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ember Therapeutics' price. Additionally, you may evaluate how the addition of Ember Therapeutics to your portfolios can decrease your overall portfolio volatility.